A kind of in vitro expansion medium of umbilical cord blood hematopoietic stem cells and its application
A technology for in vitro expansion of hematopoietic stem cells, applied in the field of in vitro expansion medium for umbilical cord blood hematopoietic stem cells, can solve the problems of low cell proliferation rate, low implantation ability and hematopoietic reconstruction ability, and achieve high proliferation rate, implantation Improve the ability and rebuilding ability of hematopoietic system, promote the effect of application
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] Example 1. Effects of Medium Containing Different Concentrations of Berberine on the Proliferation of CD34+CD38-Lin- Cells in Vitro
[0027] 1. Test materials: Umbilical cord blood was collected from the Department of Obstetrics and Gynecology of Huaqiao Hospital, and the mononuclear cell isolation kit was purchased from Beijing Suolaibao Technology Co., Ltd. (article number: P9260).
[0028] 2. Test method: the collected umbilical cord blood was separated from mononuclear cells with a mononuclear cell isolation kit to obtain mononuclear cells from umbilical cord blood, and then CD34+CD38-Lin- cells were separated by immunomagnetic bead cell sorting, and used Cell purity was identified by flow cytometry.
[0029] Release berberine into 2, 5, 7, and 10 ug / ml drug solutions with IMEM basal medium, and separate the cells of P1 generation at 10 4Cells / mL were inoculated in 96-well plates, and the in vitro expansion medium of umbilical cord blood hematopoietic stem cells co...
Embodiment 2
[0031] Embodiment 2. In vitro expansion medium of umbilical cord blood hematopoietic stem cells
[0032] The medium for in vitro expansion of umbilical cord blood hematopoietic stem cells, including IMEM basal medium, also includes the following components and their concentrations: fetal bovine serum 0.05mg / mL, thrombopoietin 15ng / mL, stem cell factor 100ng / mL, human FMS-like Tyrosine kinase 3 ligand 33ng / ml, interleukin-1 0.2ng / ml, interleukin-6 0.2ng / ml, stem cell growth factor 0.2ng / ml and berberine 2ug / ml.
[0033] Preparation method: Add fetal bovine serum, thrombopoietin, stem cell factor, human FMS-like tyrosine kinase 3 ligand, interleukin-1, interleukin-6, stem cell growth factor and small Berine, mixed evenly, passed through membrane to sterilize.
Embodiment 3
[0034] Embodiment 3, in vitro expansion medium of umbilical cord blood hematopoietic stem cells
[0035] The medium for in vitro expansion of umbilical cord blood hematopoietic stem cells, including IMEM basal medium, also includes the following components and their concentrations: fetal bovine serum 0.1mg / mL, thrombopoietin 25ng / mL, stem cell factor 120ng / mL, human FMS-like Tyrosine kinase 3 ligand 45ng / ml, interleukin-1 0.3ng / ml, interleukin-6 0.6ng / ml, stem cell growth factor 0.5ng / ml and berberine 5ug / ml.
[0036] The preparation method is similar to Example 2.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com